Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Dutch investigators identify potent and selective human A3 receptor antagonist

May 22, 2000

SkyePharma and Pfizer enter second drug delivery agreement

May 22, 2000

Vertex and Novartis create new model for drug discovery

May 18, 2000

Researchers create synthetic vessels to carry biomaterials for gene therapy and other applications

May 18, 2000

Nexell forms cell therapy and gene therapy alliance with Takara Shuzo

May 15, 2000

Acadia and ArQule enter licensing agreement for lead serotonergic compounds

May 15, 2000

Oxford BioMedica acquires development rights to nitroreductase genes

May 11, 2000

Proteomics R&D at Incyte continues to yield new discoveries with diagnostic, therapeutic potential

May 10, 2000

Medarex and Centocor sign antibody development agreement

May 5, 2000

Cambridge Drug Discovery and Teijin to collaborate on novel lead compound development

April 26, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...